Relapse with plasmacytoma after upfront autologous stem cell transplantation in multiple myeloma
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Chu, Tan-Huy | - |
dc.contributor.author | Jung, Sung-Hoon | - |
dc.contributor.author | Kim, Kihyun | - |
dc.contributor.author | Lee, Jae Hoon | - |
dc.contributor.author | Mun, Yeung-Chul | - |
dc.contributor.author | Bang, Soo-Mee | - |
dc.contributor.author | Yoon, Dok Hyun | - |
dc.contributor.author | Lee, Ho Sup | - |
dc.contributor.author | Min, Chang-Ki | - |
dc.contributor.author | Lee, Je-Jung | - |
dc.date.accessioned | 2022-05-13T08:40:05Z | - |
dc.date.available | 2022-05-13T08:40:05Z | - |
dc.date.created | 2022-05-12 | - |
dc.date.issued | 2022-06 | - |
dc.identifier.issn | 0939-5555 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/84282 | - |
dc.description.abstract | Please present P values consistently.Plasmacytoma has been reported to be associated with a poor prognosis in patients with multiple myeloma (MM). In this study, we evaluated the incidence of relapse with plasmacytoma and survival outcomes after upfront autologous stem cell transplantation (ASCT). This study retrospectively analyzed the data of 303 patients with MM who underwent upfront ASCT between April 2000 and April 2018 at eight institutes in the Republic of Korea. In total, 52 patients (17.1%) had plasmacytoma at MM relapse after upfront ASCT, of whom, 27 had paramedullary plasmacytoma (PMD) and 25 had extramedullary plasmacytoma (EMD). Patients with initial plasmacytoma were more likely to have plasmacytoma at MM relapse than those without initial plasmacytoma (37.1% vs. 11.2%). Over a median follow-up of 66.0 months, patients with plasmacytoma at relapse had significantly inferior overall survival (OS) than those without plasmacytoma (43.9 vs. 100.7 months, P < 0.001), but the OS did not significantly differ between patients with EMD and those with PMD (42.2 vs. 56.6 months, P=0.464). After MM relapse, all patients received salvage therapy, and progression-free survival after relapse was significantly shorter in patients with plasmacytoma than in those without (6.4 vs. 12.4 months, P = 0.007). This study showed that plasmacytoma frequently developed at MM relapse after upfront ASCT in patients with plasmacytoma at the time of diagnosis. Plasmacytoma at relapse was significantly associated with a poor prognosis. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | SPRINGER | - |
dc.relation.isPartOf | ANNALS OF HEMATOLOGY | - |
dc.title | Relapse with plasmacytoma after upfront autologous stem cell transplantation in multiple myeloma | - |
dc.type | Article | - |
dc.type.rims | ART | - |
dc.description.journalClass | 1 | - |
dc.identifier.wosid | 000786493500001 | - |
dc.identifier.doi | 10.1007/s00277-022-04776-0 | - |
dc.identifier.bibliographicCitation | ANNALS OF HEMATOLOGY, v.101, no.6, pp.1217 - 1226 | - |
dc.description.isOpenAccess | N | - |
dc.identifier.scopusid | 2-s2.0-85128539506 | - |
dc.citation.endPage | 1226 | - |
dc.citation.startPage | 1217 | - |
dc.citation.title | ANNALS OF HEMATOLOGY | - |
dc.citation.volume | 101 | - |
dc.citation.number | 6 | - |
dc.contributor.affiliatedAuthor | Lee, Jae Hoon | - |
dc.type.docType | Article | - |
dc.subject.keywordAuthor | Plasmacytoma | - |
dc.subject.keywordAuthor | Autologous stem cell transplantation | - |
dc.subject.keywordAuthor | Multiple myeloma | - |
dc.subject.keywordPlus | EXTRAMEDULLARY DISEASE | - |
dc.subject.keywordPlus | DEXAMETHASONE | - |
dc.subject.keywordPlus | THERAPY | - |
dc.subject.keywordPlus | LENALIDOMIDE | - |
dc.subject.keywordPlus | MULTICENTER | - |
dc.subject.keywordPlus | DARATUMUMAB | - |
dc.subject.keywordPlus | BORTEZOMIB | - |
dc.subject.keywordPlus | PROGNOSIS | - |
dc.subject.keywordPlus | IMPACT | - |
dc.subject.keywordPlus | ERA | - |
dc.relation.journalResearchArea | Hematology | - |
dc.relation.journalWebOfScienceCategory | Hematology | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
1342, Seongnam-daero, Sujeong-gu, Seongnam-si, Gyeonggi-do, Republic of Korea(13120)031-750-5114
COPYRIGHT 2020 Gachon University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.